CompletedPhase 2NCT04375098

Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection

Studying Severe acute respiratory syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Pontificia Universidad Catolica de Chile
Principal Investigator
Maria Elvira Balcells, MD
ebalcells@uc.cl
Intervention
COVID-19 convalescent plasma(biological)
Enrollment
58 target
Eligibility
18 years · All sexes
Timeline
20202020

Study locations (1)

Collaborators

Fundacion Arturo Lopez Perez

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04375098 on ClinicalTrials.gov

Other trials for Severe acute respiratory syndrome

Additional recruiting or active studies for the same condition.

See all trials for Severe acute respiratory syndrome

← Back to all trials